On May 21, 2019 Health Canada released a MedEffect Notice advising of a risk of serious drug-induced liver injury, at times resulting in acute liver failure and requiring a transplant for patients using ACTEMRA. It is an intravenous and subcutaneous drug prescribed for treatment of Rheumatoid Arthritis, Giant Cell Arteritis, Polyarticular Juvenile Idiopathic Arthritis and...Read More